Keyword: Pharmaceuticals

News

Valeant CEO Agrees to Senate Deposition

14.04.2016 - Michael Pearson, the controversial CEO of Valeant Pharmaceuticals has bowed to pressure and agreed to be deposed by the US Senate’s Special Committee on Aging, which is...

News

GSK and Miltenyi Biotec in Cell and Gene Therapy Pact

22.03.2016 - Britain’s largest pharmaceutical company, Glaxo SmithKline (GSK), has formed a strategic collaboration with German biotechnology firm Miltenyi Biotec to develop cell and gene...

News

Restrictions on Drug Trials Proposed After French Death

17.03.2016 - Pharmaceutical producers performing clinical trials with new drugs should be much more careful in the design of studies, an academic panel reviewing a recent deadly incident in...

News

Ipsen Pays $855 Million for Exelixis’ Cancer Drug

07.03.2016 - French pharmaceutical company Ipsen is paying up to $855 million for the rights to Exelixis’ cancer drug Cabozantinib. Under the deal, Exelixis gains exclusive commercialization...

News

UAE Scores with International Drugmakers

19.02.2016 - The United Arab Emirates is gaining popularity as a manufacturing base for pharmaceuticals, according to the country’s health ministry. Speaking to journalists at the recent Pharma...

News

GSK Chief Says UK “Better in EU”

05.02.2016 - Glaxo SmithKline CEO Andrew Witty has become the first pharmaceutical or chemical company executive to come out in favor of the UK remaining in the EU, although business leaders in...

News

Global Data Sees Indian Generics Soaring

29.01.2016 - The value of the Indian pharmaceutical market is set to nearly quadruple over the next five years, soaring from $20 billion in 2015 to $55 billion by 2020, according to GlobalData...

News

Dr. Wolff Licenses Tripeptide to China’s Link Health

25.01.2016 - German pharmaceutical company Dr. Wolff Group has agreed to license its new tripeptide substance, KdPT, to China’s Link Health for further development. The tripeptide has shown...